1Petri M. infection in systemic lupus erythematosus[J]. Rhum Dis Clin North Am, 1998,24:423-446.
2Cervera R, Khamashta MA, Font J, et al. Morbidity and mor- tality in systemic lupus erythematosus during a 5-year period: a multicenter prospeetive study of 1000 patients. European Working Party on Systemic lupus erythematosus[J]. Medecine (Baltimore), 1999,17 : 167-175.
6Bosch X, Guilabert A, Pallares L, et al. Infections in systemic lupus erythematosus., a prospective and controlled study of 110 patients[J]. Lupus , 2006,15 (9) : 584-589.
7Ng WL,Chu CM, Wu AK, et al. Lymphopenia at presentation is associated with increased risk of infections in patients with systemic lupus erythematosus[J]. QIM, 2006,99(1) : 37-47.
9Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 1997, 40: 1725.
10Bombardier C, Gland DD, Urowitz MB, et al. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum, 1992, 35: 630-640.
4Kim H J,Brown M S,lashoff R E,et al.HRCT定量评估硬皮病肺病口服环磷酰胺后1年的纤维网格状表现的变化[J].国际医学放射学杂志,2012,35(1):96.
5Cervera R, Khamashta MA, Font J, el al, Morbidity and mor tality in systemic lupus erythematosus during a 10-year peri od: a comparison of early and latemanifestations in a cohort of 1,000 patients[J]. Medicine( Baltimore), 2003,82 ( 5 ) : 299-308.
6Rahma'n A, Isenberg DA. Systemic lupus erythematosus[J]. JMed,2008,358(9):929-39.
